Crinetics Pharmaceuticals Inc (CRNX)
57.03
+0.96
(+1.71%)
USD |
NASDAQ |
Nov 21, 16:00
57.00
-0.03
(-0.05%)
After-Hours: 20:00
Crinetics Pharmaceuticals Shareholders Equity (Quarterly): 832.98M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 832.98M |
| June 30, 2024 | 830.76M |
| March 31, 2024 | 874.93M |
| December 31, 2023 | 539.11M |
| September 30, 2023 | 547.75M |
| June 30, 2023 | 254.12M |
| March 31, 2023 | 280.33M |
| December 31, 2022 | 316.33M |
| September 30, 2022 | 351.37M |
| June 30, 2022 | 386.16M |
| March 31, 2022 | 303.04M |
| December 31, 2021 | 331.94M |
| September 30, 2021 | 193.59M |
| June 30, 2021 | 201.44M |
| Date | Value |
|---|---|
| March 31, 2021 | 149.48M |
| December 31, 2020 | 168.92M |
| September 30, 2020 | 187.22M |
| June 30, 2020 | 202.77M |
| March 31, 2020 | 108.44M |
| December 31, 2019 | 117.14M |
| September 30, 2019 | 129.52M |
| June 30, 2019 | 142.10M |
| March 31, 2019 | 152.39M |
| December 31, 2018 | 160.22M |
| September 30, 2018 | 167.52M |
| June 30, 2018 | -25.18M |
| March 31, 2018 | -19.98M |
| December 31, 2017 | -15.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
108.44M
Minimum
Mar 2020
874.93M
Maximum
Mar 2024
358.89M
Average
291.69M
Median
Shareholders Equity (Quarterly) Benchmarks
| Clearside Biomedical Inc | -34.79M |
| Biomea Fusion Inc | 75.97M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.37M |
| Total Liabilities (Quarterly) | 104.39M |